221 related articles for article (PubMed ID: 30445932)
1. BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway.
Wang F; Chen Q; Huang G; Guo X; Li N; Li Y; Li B
BMC Cancer; 2018 Nov; 18(1):1128. PubMed ID: 30445932
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.
Zhou L; Cai B; Bao W; He YY; Chen XY; Yang YX; Liu XL; Wan XP
Int J Gynecol Cancer; 2011 Nov; 21(8):1357-65. PubMed ID: 21720253
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
4. [Estradiol activates MAPK signaling pathway by estrogen induced VEGF and bFGF in endometrial cancer cells].
Lu Y; Jiang S; Zhang J; Song H; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):925-31. PubMed ID: 25608994
[TBL] [Abstract][Full Text] [Related]
5. Ca2+ channel subunit α 1D promotes proliferation and migration of endometrial cancer cells mediated by 17β-estradiol via the G protein-coupled estrogen receptor.
Hao J; Bao X; Jin B; Wang X; Mao Z; Li X; Wei L; Shen D; Wang JL
FASEB J; 2015 Jul; 29(7):2883-93. PubMed ID: 25805831
[TBL] [Abstract][Full Text] [Related]
6. SPRY4-mediated ERK1/2 signaling inhibition abolishes 17β-estradiol-induced cell growth in endometrial adenocarcinoma cell.
Li M; Zhang H; Zhao X; Yan L; Wang C; Li C; Li C
Gynecol Endocrinol; 2014 Aug; 30(8):600-4. PubMed ID: 24811094
[TBL] [Abstract][Full Text] [Related]
7. The role of BKCa in endometrial cancer HEC-1-B cell proliferation and migration.
Li N; Liu L; Li G; Xia M; Du C; Zheng Z
Gene; 2018 May; 655():42-47. PubMed ID: 29477869
[TBL] [Abstract][Full Text] [Related]
8. Dual-specificity phosphatase 6 (Dusp6), a negative regulator of FGF2/ERK1/2 signaling, enhances 17β-estradiol-induced cell growth in endometrial adenocarcinoma cell.
Zhang H; Guo Q; Wang C; Yan L; Fu Y; Fan M; Zhao X; Li M
Mol Cell Endocrinol; 2013 Aug; 376(1-2):60-9. PubMed ID: 23419500
[TBL] [Abstract][Full Text] [Related]
9. Normal endometrial stromal cells regulate 17β-estradiol-induced epithelial-mesenchymal transition via slug and E-cadherin in endometrial adenocarcinoma cells in vitro.
Zhang H; Li H; Qi S; Liu Z; Fu Y; Li M; Zhao X
Gynecol Endocrinol; 2017 Jan; 33(1):82-86. PubMed ID: 27449470
[TBL] [Abstract][Full Text] [Related]
10. Molecular interaction and functional coupling between type 3 inositol 1,4,5-trisphosphate receptor and BKCa channel stimulate breast cancer cell proliferation.
Mound A; Rodat-Despoix L; Bougarn S; Ouadid-Ahidouch H; Matifat F
Eur J Cancer; 2013 Nov; 49(17):3738-51. PubMed ID: 23992640
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
12. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.
Kashima H; Shiozawa T; Miyamoto T; Suzuki A; Uchikawa J; Kurai M; Konishi I
Endocr Relat Cancer; 2009 Mar; 16(1):113-22. PubMed ID: 18852162
[TBL] [Abstract][Full Text] [Related]
13. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
Zhang SQ; Cai B; Liu L; He YY; Yang YX; Wan XP
Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
[TBL] [Abstract][Full Text] [Related]
14. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways.
Wang Y; Gao C; Zhang Y; Gao J; Teng F; Tian W; Yang W; Yan Y; Xue F
Gynecol Oncol; 2016 Oct; 143(1):168-178. PubMed ID: 27473926
[TBL] [Abstract][Full Text] [Related]
15. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway.
He YY; Cai B; Yang YX; Liu XL; Wan XP
Cancer Sci; 2009 Jun; 100(6):1051-61. PubMed ID: 19432902
[TBL] [Abstract][Full Text] [Related]
16. PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.
Keightley MC; Sales KJ; Jabbour HN
BMC Cancer; 2010 Sep; 10():488. PubMed ID: 20840749
[TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation.
Manohar M; Fatima I; Saxena R; Chandra V; Sankhwar PL; Dwivedi A
J Nutr Biochem; 2013 Jun; 24(6):940-7. PubMed ID: 22959059
[TBL] [Abstract][Full Text] [Related]
18. Dusp6 inhibits epithelial-mesenchymal transition in endometrial adenocarcinoma via ERK signaling pathway.
Fan MJ; Liang SM; He PJ; Zhao XB; Li MJ; Geng F
Radiol Oncol; 2019 Sep; 53(3):307-315. PubMed ID: 31553703
[TBL] [Abstract][Full Text] [Related]
19. Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation.
Liu Y; Lv L; Xiao W; Gong C; Yin J; Wang D; Sheng H
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):365. PubMed ID: 21671179
[TBL] [Abstract][Full Text] [Related]
20. Estrogen/estrogen receptor promotes the proliferation of endometrial carcinoma cells by enhancing hMOF expression.
Qi Y; Tan M; Zheng M; Jin S; Wang H; Liu J; Wang P; Nie X; Gao L; Lin B
Jpn J Clin Oncol; 2020 Mar; 50(3):241-253. PubMed ID: 31990345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
